CJC-1295 without DAC, also known as Modified GRF (1-29), is a truncated GHRH fragment with a short half-life. Because its release profile more closely resembles the natural pulsatile pattern, it is a standard reference point in GH/IGF-1 axis research. The 10mg presentation was chosen to suit the scale of work you are running.
Purity of ≥99.4% with identity confirmed by LC-MS and endotoxin testing at <0.5 EU/mg on every production batch.
The dry vial is stable at 2–8 °C away from direct light; reconstituted solution is best used within 3–4 weeks. Delivery across Indonesia using secure packaging.
For in-vitro and laboratory research use only.